Pharmacogenomics of osteoporosis: opportunities and challenges.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of musculoskeletal & neuronal interactions

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16675890
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin D receptor genotypes and changes of bone density in physically active German women with high calcium intake.

  2009cited by this paper
• Polymorphisms of the interleukin-6 gene are associated with bone mineral density

  2006cited by this paper
• Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites.

  2004cited by this paper
• Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes.

  2003cited by this paper
• Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.

  2003cited by this paper
• Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: relationship with BsmI vitamin D receptor genotypes

  2003cited by this paper
• Diagnosis of osteoporosis and assessment of fracture risk.

  2002cited by this paper
• High bone density due to a mutation in LDL-receptor-related protein 5.

  2002cited by this paper
• Epidemiology and outcomes of osteoporotic fractures.

  2002cited by this paper
• A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait.

  2002cited by this paper
• High bone density due to a mutation in LDL-receptor-related protein 5.

  2002cited by this paper
• Treatment of postmenopausal osteoporosis.

  2002cited by this paper
• The Sequence of the Human Genome

  2001cited by this paper
• Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis*

  2001cited by this paper
• LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

  2001cited by this paper
• Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays.

  2001cited by this paper
• Advances in Pharmacogenetics and Pharmacogenomics

  2000cited by this paper
• Genetic Determination of Colles' Fracture and Differential Bone Mass in Women With and Without Colles' Fracture

  2000cited by this paper
• Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene.

  1999cited by this paper
• Pharmacogenomics: translating functional genomics into rational therapeutics.

  1999cited by this paper
• Vitamin D Receptor Gene Fok1 Polymorphism Predicts Calcium Absorption and Bone Mineral Density in Children

  1999cited by this paper
• Mortality after all major types of osteoporotic fracture in men and women: an observational study.

  1999cited by this paper
• Vitamin D receptor 3'-untranslated region polymorphisms: lack of effect on mRNA stability.

  1999cited by this paper
• Genetic factors and osteoporotic fractures in elderly people: prospective 25 year follow up of a nationwide cohort of elderly Finnish twins

  1999cited by this paper
• Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system

  1999cited by this paper
• Racial differences in the outcome of left ventricular dysfunction.

  1999cited by this paper
• Familial Resemblance of Bone Mineral Density (BMD) and Calcaneal Ultrasound Attenuation: The BMD in Mothers and Daughters Study

  1999cited by this paper
• Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenoposal Japanese women

  1999cited by this paper
• HLA-A*24-B*07-DRB1*01 haplotype implicated with genetic disposition of peak bone mass in healthy young Japanese women.

  1998cited by this paper
• Genetic and environmental correlations between bone formation and bone mineral density: a twin study.

  1998cited by this paper
• Genomics Research and Human Subjects

  1998cited by this paper
• A Novel Polymorphism in the Promoter Region for the Human Osteocalcin Gene: The Possibility of a Correlation with Bone Mineral Density in Postmenopausal Japanese Women

  1998cited by this paper
• A 4-Mb high-density single nucleotide polymorphism-based map around human APOE.

  1998cited by this paper
• Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine.

  1998cited by this paper
• Allelic variation in the vitamin D receptor, lifestyle factors and lumbar spinal degenerative disease

  1998cited by this paper
• Bone mass, lean mass, and fat mass: same genes or same environments?

  1998cited by this paper
• A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies.

  1998cited by this paper
• Bone Mineral Density and Its Change in White Women: Estrogen and Vitamin D Receptor Genotypes and Their Interaction

  1998cited by this paper
• Bone Fracture History and Prospective Bone Fracture Risk of Hemodialysis Patients are Related to Apolipoprotein E Genotype

  1998cited by this paper
• Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women.

  1998cited by this paper
• Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts.

  1998cited by this paper
• Genetic Variation in α2HS-Glycoprotein Is Related to Calcaneal Broadband Ultrasound Attenuation in Older Women

  1998cited by this paper
• Genetic and Environmental Contributions to the Association Between Quantitative Ultrasound and Bone Mineral Density Measurements: A Twin Study

  1998cited by this paper
• Vitamin D receptor gene polymorphisms: analysis of ligand binding and hormone responsiveness in cultured skin fibroblasts.

  1998cited by this paper
• Association of a Polymorphism of the Transforming Growth Factor‐β1 Gene with Genetic Susceptibility to Osteoporosis in Postmenopausal Japanese Women

  1998cited by this paper
• Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density.

  1998cited by this paper
• Genetic Influences on Muscle Strength, Lean Body Mass, and Bone Mineral Density: A Twin Study

  1997cited by this paper
• The BsmI Vitamin D Receptor Restriction Fragment Length Polymorphism (bb) Influences the Effect of Calcium Intake on Bone Mineral Density

  1997cited by this paper
• Pharmacogenetics in biological perspective.

  1997cited by this paper
• Effect of Vitamin D Receptor Genotypes on Calcium Absorption, Duodenal Vitamin D Receptor Concentration, and Serum 1,25 Dihydroxyvitamin D Levels in Normal Women

  1997cited by this paper
• Vitamin D receptor gene polymorphism is associated with urinary calcium excretion but not with bone mineral density in postmenopausal women

  1997cited by this paper
• Association of early osteoarthritis of the knee with a Taq I polymorphism of the vitamin D receptor gene.

  1997cited by this paper
• Vitamin D receptor genotype is associated with radiographic osteoarthritis at the knee.

  1997cited by this paper
• Lack of relationship between vitamin D receptor genotype and forearm bone gain in healthy children, adolescents, and young adults.

  1997cited by this paper
• Vitamin D receptor alleles b, a, and T: risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN 1.

  1997cited by this paper
• Association Between Intestinal Vitamin D Receptor, Calcium Absorption, and Serum 1,25 Dihydroxyvitamin D in Normal Young and Elderly Women

  1997cited by this paper
• Vitamin D Receptor Gene Polymorphisms, Bone Turnover, and Rates of Bone Loss in Older African‐American Women

  1997cited by this paper
• A Vitamin D Receptor Gene Polymorphism in the Translation Initiation Codon: Effect on Protein Activity and Relation to Bone Mineral Density in Japanese Women

  1997cited by this paper
• The Effect of Vitamin D Supplementation on the Bone Mineral Density of the Femoral Neck Is Associated with Vitamin D Receptor Genotype

  1997cited by this paper
• Association of Bone Mineral Density with Apolipoprotein E Phenotype

  1997cited by this paper
• Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes.

  1997cited by this paper
• Relations between calcium intake, calcitriol, polymorphisms of the vitamin D receptor gene, and calcium absorption in premenopausal women.

  1997cited by this paper
• Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13)

  1997cited by this paper
• Quantification of Vitamin D Receptor mRNA by Competitive Polymerase Chain Reaction in PBMC: Lack of Correspondence with Common Allelic Variants

  1997cited by this paper
• Vitamin D receptor gene polymorphism in men and its effect on bone density and calcium absorption

  1997cited by this paper
• Relation of common allelic variation at vitamin D receptor locus to bone mineral density and postmenopausal bone loss: cross sectional and longitudinal population study

  1996cited by this paper
• Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13.

  1996cited by this paper
• Association of bone mineral density with polymorphism of the estrogen receptor gene

  1996cited by this paper
• Allelic variants of human calcitonin receptor in the Japanese population

  1996cited by this paper
• Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

  1996cited by this paper
• Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 gene

  1996cited by this paper
• Genetic influence on bone turnover in postmenopausal twins.

  1996cited by this paper
• Genetic influences on bone density: physiological correlates of vitamin D receptor gene alleles in premenopausal women.

  1995cited by this paper
• Genetic Factors in Drug Therapy: Clinical and Molecular Pharmacogenetics

  1995cited by this paper
• Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

  1995cited by this paper
• Vitamin D receptor alleles and rates of bone loss: Influences of years since menopause and calcium intake

  1995cited by this paper
• Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density.

  1995cited by this paper
• Vitamin D receptor genotypes in primary hyperparathyroidism

  1995cited by this paper
• Molecular basis of polymorphic drug metabolism

  1995cited by this paper
• Vitamin D receptor gene polymorphism, bone mass, body size, and vitamin D receptor density

  1995cited by this paper
• Determinants of bone mass in 10‐ to 26‐year‐old females: A twin study

  1995cited by this paper
• Bone density determinants in elderly women: A twin study

  1995cited by this paper
• Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype.

  1995cited by this paper
• Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnover.

  1994cited by this paper
• The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.

  1994cited by this paper
• Prediction of bone density from vitamin D receptor alleles

  1994cited by this paper
• Reduced femoral neck bone density in the daughters of women with hip fractures: The role of low peak bone density in the pathogenesis of osteoporosis

  1994cited by this paper
• Pharmacogenetic Phenotyping and Genotyping

  1994cited by this paper
• Vitamin D receptor gene polymorphism and bone mineral density in healthy Japanese women.

  1994cited by this paper
• Genetically variable metabolism of antidepressants and neuroleptic drugs in man.

  1993cited by this paper
• Prediction of osteoporotic fractures by postural instability and bone density.

  1993cited by this paper
• Long‐term fracture prediction by bone mineral assessed at different skeletal sites

  1993cited by this paper
• Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin.

  1992cited by this paper
• Clinical implications of variable antiarrhythmic drug metabolism.

  1992cited by this paper
• Reduced bone mass in daughters of women with osteoporosis.

  1989cited by this paper
• Age and bone mass as predictors of fracture in a prospective study.

  1988cited by this paper
• Bone mass is low in relatives of osteoporotic patients.

  1988cited by this paper
• Genetic determinants of bone mass in adults. A twin study.

  1987cited by this paper
• Sequence the Human Genome

  1986cited by this paper
• Genetic factors in determining bone mass.

  1973cited by this paper

• Bone Health Management in the Continuum of Prostate Cancer Disease

  2022cites this paper
• Orthoses for Osteoporosis

  2019cites this paper
• The estrogen receptor 1 gene affects bone mineral density and osteoporosis treatment efficiency in Slovak postmenopausal women

  2018cites this paper
• Pharmacogenetics and Pharmacogenomics of Osteoporosis: Personalized Medicine Outlook

  2018cites this paper
• Lack of Influence of Vitamin D Receptor BsmI (rs1544410) Polymorphism on the Rate of Bone Loss in a Cohort of Postmenopausal Spanish Women Affected by Osteoporosis and Followed for Five Years

  2015cites this paper
• Efficacy of Zoledronic Acid in Patients with Systemic Osteoporosis and Problem of «Non Respondents» to the Treatment

  2015cites this paper
• Genetic factors influencing bone mineral content in a black South African population

  2013cites this paper
• Translational Genetics of Osteoporosis: From Population Association to Individualized Prognosis

  2013cites this paper
• Genetic factors influencing bone health in the black South African population

  2012influential citation
• Bone mass and exercise in adult premenopausal women

  2012cites this paper
• Pharmacogenetics of Osteoporosis: What is the Evidence?

  2012cites this paper
• The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal women: A pilot study

  2011cites this paper
• Predictive genetic testing for the identification of high-risk groups: a simulation study on the impact of predictive ability

  2011cites this paper
• Bisphosphonates pathway.

  2011cites this paper
• Pharmacogenetics of osteoporosis

  2010cites this paper
• Pharmacogenetics of osteoporosis-related bone fractures: moving towards the harmonization and validation of polymorphism diagnostic tools.

  2010cites this paper
• Pharmacogenetics of osteoporosis

  2010cites this paper
• Pharmacogenomics in osteoporosis: Steps toward personalized medicine

  2009influential citation
• Pharmacogenetics of Osteoporosis: Future Perspectives

  2009cites this paper
• Enhancement of Absolute Fracture Risk Prognosis with Genetic Marker: The Collagen I Alpha 1 Gene

  2009cites this paper
• Effect of Electromagnetic Field Induced by Radio Frequency Waves at 900 to 1800 MHz on Bone Mineral Density of Iliac Bone Wings

  2009cites this paper
• Fat-free mass, strength, and sarcopenia are related to bone mineral density in older women.

  2009cites this paper
• Vitamin-d-receptor genotypes and bone-mineral density in postmenopausal women: interaction with physical activity.

  2009influential citation
• PHARMACOGENOMICS - A NEW PERSPECTIVE IN CLINICAL HEALTHCARE

  2007cites this paper
• Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review

  2007cites this paper
• Bmc Medical Genetics Association between Lrp5 Polymorphism and Bone Mineral Density: a Bayesian Meta-analysis

  year unknowncites this paper